Pharming Group/$PHAR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pharming Group
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Ticker
$PHAR
Sector
Primary listing
Employees
407
Headquarters
Website
Pharming Group Metrics
BasicAdvanced
$937m
817.70
$0.02
0.12
-
Price and volume
Market cap
$937m
Beta
0.12
52-week high
$21.34
52-week low
$9.54
Average daily volume
9.6k
Financial strength
Current ratio
2.63
Quick ratio
2.049
Long term debt to equity
40.177
Total debt to equity
43.205
Interest coverage (TTM)
4.20%
Profitability
EBITDA (TTM)
42.282
Gross margin (TTM)
88.14%
Net profit margin (TTM)
3.34%
Operating margin (TTM)
9.44%
Effective tax rate (TTM)
38.57%
Revenue per employee (TTM)
$910,000
Management effectiveness
Return on assets (TTM)
4.89%
Return on equity (TTM)
5.04%
Valuation
Price to earnings (TTM)
817.703
Price to revenue (TTM)
25.551
Price to book
3.23
Price to tangible book (TTM)
6.29
Price to free cash flow (TTM)
169.42
Free cash flow yield (TTM)
0.59%
Free cash flow per share (TTM)
0.079
Growth
Revenue change (TTM)
15.21%
Earnings per share change (TTM)
-176.69%
3-year revenue growth (CAGR)
22.39%
10-year revenue growth (CAGR)
39.77%
3-year earnings per share growth (CAGR)
66.89%
10-year earnings per share growth (CAGR)
-7.16%
Pharming Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs